Product References
Genetic and phenotypic diversity in breast tumor metastases.
Cancer research
Almendro V,Kim HJ,Cheng YK,Gönen M,Itzkovitz S,Argani P,van Oudenaarden A,Sukumar S,Michor F,Polyak K
MA5-13887 was used in immunohistochemistry to study the diversity of breast cancer metastases at the genetic and phenotypic levels
Sat Mar 01 00:00:00 EST 2014
Y-box-binding protein 1 (YB1) in breast carcinomas: relation to aggressive tumor phenotype and identification of patients at high risk for relapse.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Mylona E,Melissaris S,Giannopoulou I,Theohari I,Papadimitriou C,Keramopoulos A,Nakopoulou L
MA5-13887 was used in immunohistochemistry to study the prognostic and clinical value of the Y-box-binding protein-1 expression pattern in breast carcinoma patients
Sat Mar 01 00:00:00 EST 2014
CD44/CD24 as potential prognostic markers in node-positive invasive ductal breast cancer patients treated with adjuvant chemotherapy.
Journal of molecular histology
Adamczyk A,Niemiec JA,Ambicka A,Mucha-Małecka A,Mituś J,Ryś J
MA5-13887 was used in immunohistochemistry to study the prognostic and clinical significance of CD44/CD24 expression in node-positive invasive ductal breast cancer
Sat Feb 01 00:00:00 EST 2014
Isolation and characterization of cancer stem cells from high-grade serous ovarian carcinomas.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
He QZ,Luo XZ,Wang K,Zhou Q,Ao H,Yang Y,Li SX,Li Y,Zhu HT,Duan T
MA5-13887 was used in flow cytometry to study high-grade serous ovarian carcinoma cancer stem cells
Mon Jul 18 00:00:00 EDT 2016
Histological and prognostic importance of CD44(+) /CD24(+) /EpCAM(+) expression in clinical pancreatic cancer.
Cancer science
Ohara Y,Oda T,Sugano M,Hashimoto S,Enomoto T,Yamada K,Akashi Y,Miyamoto R,Kobayashi A,Fukunaga K,Morishita Y,Ohkohchi N
MA5-13887 was used in immunohistochemistry to study the clinical significance of CD44(+)/CD24(+)/EpCAM(+) cells in pancreatic cancer
Thu Aug 01 00:00:00 EDT 2013
Triple negative breast tumors in African-American and Hispanic/Latina women are high in CD44+, low in CD24+, and have loss of PTEN.
PloS one
Wu Y,Sarkissyan M,Elshimali Y,Vadgama JV
MA5-13887 was used in immunohistochemistry to study the prevalence of the high CD44(+)/low CD24(+) coupled with PTEN loss phenotype of triple-nagative breast cancer of African-American and Hispanic/Latina women in an Amercican population
Wed May 28 00:00:00 EDT 2014
Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.
The American journal of pathology
Kagara N,Huynh KT,Kuo C,Okano H,Sim MS,Elashoff D,Chong K,Giuliano AE,Hoon DS
MA5-13887 was used in immunohistochemistry to study the regulation of cancer stem cell genes at the epigenetic level in triple-negative breast cancer
Sun Jul 01 00:00:00 EDT 2012
Immunohistochemical detection of breast cancer stem cells in hormone receptor-positive breast cancer and their role in response to endocrine therapy and clinical outcome.
Oncology
Hashimoto K,Shimizu C,Tsuda H,Saji S,Osaki A,Shigekawa T,Aogi K
MA5-13887 was used in immunohistochemistry to study the role of breast cancer stem cells in the response of hormone receptor-positive breast cancer to endocrine therapy
Thu Jun 21 00:00:00 EDT 2012
Neoadjuvant chemotherapy with gemcitabine for pancreatic cancer increases in situ expression of the apoptosis marker M30 and stem cell marker CD44.
Oncology letters
Tajima H,Ohta T,Kitagawa H,Okamoto K,Sakai S,Kinoshita J,Makino I,Furukawa H,Hayashi H,Nakamura K,Oyama K,Inokuchi M,Nakagawara H,Fujita H,Takamura H,Ninomiya I,Fushida S,Tani T,Fujimura T,Kitamura S,Ikeda H,Tsuneyama K
MA5-13887 was used in immunohistochemistry to study the increased expression of M30 and CD44 in resected pancreatic cancer samples following neoadjuvant chemotherapy with gemcitabine
Fri Jun 01 00:00:00 EDT 2012
CD44 is associated with tumor recurrence and is an independent poor prognostic factor for patients with localized clear cell renal cell carcinoma after nephrectomy.
Experimental and therapeutic medicine
Jeong BJ,Liang ZL,Huang SM,Lim JS,Kim JM,Lee HJ
MA5-13887 was used in immunohistochemistry to study the prognostic value of the immunohistochemical expression of CD44 in patients with localized clear cell renal cell carcinoma
Tue May 01 00:00:00 EDT 2012
The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.
The Journal of clinical investigation
Marotta LL,Almendro V,Marusyk A,Shipitsin M,Schemme J,Walker SR,Bloushtain-Qimron N,Kim JJ,Choudhury SA,Maruyama R,Wu Z,Gönen M,Mulvey LA,Bessarabova MO,Huh SJ,Silver SJ,Kim SY,Park SY,Lee HE,Anderson KS,Richardson AL,Nikolskaya T,Nikolsky Y,Liu XS,Root DE,Hahn WC,Frank DA,Polyak K
MA5-13887 was used in immunocytochemistry to identify treatment targets common to breast tumor subpopulations
Fri Jul 01 00:00:00 EDT 2011
An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer.
British journal of cancer
Lee HE,Kim JH,Kim YJ,Choi SY,Kim SW,Kang E,Chung IY,Kim IA,Kim EJ,Choi Y,Ryu HS,Park SY
MA5-13887 was used in immunohistochemistry to study the increase in cancer stem cell numbers after primary systemic therapy as a poor prognostic factor in breast cancer
Tue May 24 00:00:00 EDT 2011
A comprehensive characterization study of human bone marrow mscs with an emphasis on molecular and ultrastructural properties.
Journal of cellular physiology
Karaöz E,Okçu A,Gacar G,Sağlam O,Yürüker S,Kenar H
MA5-13887 was used in immunocytochemistry to study the molecular and ultrastructural properties of human bone marrow-derived mesenchymal stem cells
Sun May 01 00:00:00 EDT 2011
Expression of CD44 and MMP-2: possible association with histopathological features of pleuro-pulmonary solitary fibrous tumors.
Turk patoloji dergisi
Demırağ F,Cakir E,Alpar S,Taştepe I,Kaya S
MA5-13887 was used in immunohistochemistry to investigate the relationship between the level of CD44/MMP-2 and histopathological characteristics in solitary fibrous tumors
Sun May 01 00:00:00 EDT 2011
Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.
International journal of molecular sciences
Ween MP,Oehler MK,Ricciardelli C
MA5-13887 was used in immunohistochemistry to study the role of versican, hyaluronan and CD44 in ovarian cancer metastasis
Mon Jan 31 00:00:00 EST 2011
Novel immunofluorescence protocol for multimarker assessment of putative disseminating breast cancer stem cells.
Applied immunohistochemistry & molecular morphology : AIMM
Balic M,Rapp N,Stanzer S,Lin H,Strutz J,Szkandera J,Daidone MG,Samonigg H,Cote RJ,Dandachi N
MA5-13887 was used in immunohistochemistry to investigate the efficiency of a new method for the assessment of putative disseminating breast cancer stem cells
Sat Jan 01 00:00:00 EST 2011
Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype.
The Journal of clinical investigation
Park SY,Gönen M,Kim HJ,Michor F,Polyak K
MA5-13887 was used in immunohistochemistry to identify the sources of genetic diversity in human breast tumors
Mon Feb 01 00:00:00 EST 2010
Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Seegmiller AC,Garcia R,Huang R,Maleki A,Karandikar NJ,Chen W
MA5-13887 was used in immunohistochemistry to characterize the relationship between karyotype and lymphomas
Thu Jul 01 00:00:00 EDT 2010
Aggressive progression of breast cancer with microscopic pulmonary emboli possessing a stem cell-like phenotype independent of its origin.
Pathology international
Kawasaki H,Ogura H,Arai Y,Baba S,Kosugi I,Tsutsui Y,Iwashita T
MA5-13887 was used in immunohistochemistry to investigate the stem-like characteristics of microscopic pulmonary emboli
Mon Mar 01 00:00:00 EST 2010
Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research
Tanei T,Morimoto K,Shimazu K,Kim SJ,Tanji Y,Taguchi T,Tamaki Y,Noguchi S
MA5-13887 was used in immunohistochemistry to study whether cancer stem cells are clinically significant for resistance to chemotherapy in human breast cancers
Mon Jun 15 00:00:00 EDT 2009
CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells.
International journal of cancer
Hong SP,Wen J,Bang S,Park S,Song SY
MA5-13887 was used in immunohistochemistry to study the role of CD44-positive cells in gemcitabine resistance in pancreatic cancer
Sun Nov 15 00:00:00 EST 2009
Identification of CD44v6(+)/CD24- breast carcinoma cells in primary human tumors by quantum dot-conjugated antibodies.
Laboratory investigation; a journal of technical methods and pathology
Snyder EL,Bailey D,Shipitsin M,Polyak K,Loda M
MA5-13887 was used in immunohistochemistry to identify CD44v6(+)/CD24- human breast carcinoma cells using quantum dot-conjugated antibodies
Sat Aug 01 00:00:00 EDT 2009
Plasmablastic lymphomas with MYC/IgH rearrangement: report of three cases and review of the literature.
American journal of clinical pathology
Bogusz AM,Seegmiller AC,Garcia R,Shang P,Ashfaq R,Chen W
MA5-13887 was used in immunohistochemistry to investigate the relationship between MYC/IgH rearrangements and plasmablastic lymphomas
Thu Oct 01 00:00:00 EDT 2009
Expression of CD44s in incidental prostate cancer is more strongly associated with Gleason scores on subsequent radical prostatectomies than conventional prognostic parameters.
Pathobiology : journal of immunopathology, molecular and cellular biology
Gunia S,May M,Koch S,Dietel M,Erbersdobler A
MA5-13887 was used in immunohistochemistry to study the prognostic significance of CD44s in incidental prostate cancer
Thu Feb 25 00:00:00 EST 2010
Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts.
Proceedings of the National Academy of Sciences of the United States of America
Horwitz KB,Dye WW,Harrell JC,Kabos P,Sartorius CA
MA5-13887 was used in immunohistochemistry to study rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast tumors
Tue Apr 15 00:00:00 EDT 2008
The CD44+/CD24- phenotype is enriched in basal-like breast tumors.
Breast cancer research : BCR
Honeth G,Bendahl PO,Ringnér M,Saal LH,Gruvberger-Saal SK,Lövgren K,Grabau D,Fernö M,Borg A,Hegardt C
MA5-13887 was used in immunohistochemistry to study the enrichment of CD44+/CD24- cells in basal-like breast tumors
Wed Nov 12 00:00:00 EST 2008
The CD44+/CD24- phenotype is enriched in basal-like breast tumors.
Breast cancer research : BCR
Honeth G,Bendahl PO,Ringnér M,Saal LH,Gruvberger-Saal SK,Lövgren K,Grabau D,Fernö M,Borg A,Hegardt C
MA5-13887 was used in immunohistochemistry to study the enrichment of CD44+/CD24- cells in basal-like breast tumors
Wed Nov 12 00:00:00 EST 2008
Periodontal tissue engineering by transplantation of multilayered sheets of phenotypically modified gingival fibroblasts.
Journal of periodontal research
Nakajima K,Abe T,Tanaka M,Hara Y
MA5-13887 was used in immunohistochemistry to develop and evaluate a novel fibronectin graft for periodontal tissue engineering
Mon Dec 01 00:00:00 EST 2008
The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomas.
Human pathology
Mylona E,Giannopoulou I,Fasomytakis E,Nomikos A,Magkou C,Bakarakos P,Nakopoulou L
MA5-13887 was used in immunohistochemistry to study the prognostic importance of CD44(+)/CD24(-/low) and CD44(-)/CD24(+) tumor phenotypes in invasive breast carcinoma
Tue Jul 01 00:00:00 EDT 2008
Cell-surface MMP-9 regulates the invasive capacity of leukemia blast cells with monocytic features.
Cell cycle (Georgetown, Tex.)
Paupert J,Mansat-De Mas V,Demur C,Salles B,Muller C
MA5-13887 was used in flow cytometry to study the role of cell surface MMP-9 in regulating the invasive capacity of leukemia blast cells
Tue Apr 15 00:00:00 EDT 2008
IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland.
The Journal of clinical investigation
Sansone P,Storci G,Tavolari S,Guarnieri T,Giovannini C,Taffurelli M,Ceccarelli C,Santini D,Paterini P,Marcu KB,Chieco P,Bonafè M
MA5-13887 was used in immunohistochemistry to study the role of IL-6 in triggering the development of malignant features in mammospheres
Sat Dec 01 00:00:00 EST 2007
Estrogen insensitivity in a model of estrogen receptor positive breast cancer lymph node metastasis.
Cancer research
Harrell JC,Dye WW,Harvell DM,Pinto M,Jedlicka P,Sartorius CA,Horwitz KB
MA5-13887 was used in immunohistochemistry to study the lack of estrogen-sensitivity of lymph node metastases in a model of estrogen receptor positive breast cancer
Thu Nov 01 00:00:00 EDT 2007
Moesin expression is a marker of basal breast carcinomas.
International journal of cancer
Charafe-Jauffret E,Monville F,Bertucci F,Esterni B,Ginestier C,Finetti P,Cervera N,Geneix J,Hassanein M,Rabayrol L,Sobol H,Taranger-Charpin C,Xerri L,Viens P,Birnbaum D,Jacquemier J
MA5-13887 was used in immunohistochemistry to study moesin expression as a marker of basal breast carcinoma
Mon Oct 15 00:00:00 EDT 2007
Formation of hyaluronan- and versican-rich pericellular matrix by prostate cancer cells promotes cell motility.
The Journal of biological chemistry
Ricciardelli C,Russell DL,Ween MP,Mayne K,Suwiwat S,Byers S,Marshall VR,Tilley WD,Horsfall DJ
MA5-13887 was used in immunocytochemistry to study the role of the pericellular matrix in promoting prostate cancer cell motility
Fri Apr 06 00:00:00 EDT 2007
Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.
Clinical cancer research : an official journal of the American Association for Cancer Research
Balic M,Lin H,Young L,Hawes D,Giuliano A,McNamara G,Datar RH,Cote RJ
MA5-13887 was used in immunohistochemistry to characterize the early disseminated cancer cells in bone marrow of breast cancer patients
Sun Oct 01 00:00:00 EDT 2006
Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes.
Cancer research
Harrell JC,Dye WW,Allred DC,Jedlicka P,Spoelstra NS,Sartorius CA,Horwitz KB
MA5-13887 was used in immunohistochemistry to study the role of estrogen receptor in breast cancer metastasis
Fri Sep 15 00:00:00 EDT 2006
Downregulation of BRG-1 repressed expression of CD44s in cervical neuroendocrine carcinoma and adenocarcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Kuo KT,Liang CW,Hsiao CH,Lin CH,Chen CA,Sheu BC,Lin MC
MA5-13887 was used in immunohistochemistry to investigate the mechanism for CD44s regulation in cervical neuroendocrine carcinoma and adenocarcinoma
Fri Dec 01 00:00:00 EST 2006
SHAP potentiates the CD44-mediated leukocyte adhesion to the hyaluronan substratum.
The Journal of biological chemistry
Zhuo L,Kanamori A,Kannagi R,Itano N,Wu J,Hamaguchi M,Ishiguro N,Kimata K
MA5-13887 was used in immunocytochemistry and immunohistochemistry to study the role of SHAP in potentiating CD44-mediated leukocyte adhesion to the hyaluronan substratum
Fri Jul 21 00:00:00 EDT 2006
Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer.
Cancer research
Lo HW,Xia W,Wei Y,Ali-Seyed M,Huang SF,Hung MC
MA5-13887 was used in immunohistochemistry to study the prognostic value of nuclear-localized EGFR in beast cancer
Sat Jan 01 00:00:00 EST 2005
Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer.
The Prostate
Freedland SJ,Seligson DB,Liu AY,Pantuck AJ,Paik SH,Horvath S,Wieder JA,Zisman A,Nguyen D,Tso CL,Palotie AV,Belldegrun AS
MA5-13887 was used in immunohistochemistry to study the role of CD10 loss in the development of human prostate cancer
Tue Apr 01 00:00:00 EST 2003